Suppr超能文献

VCAM-targeting lipid platform brings new hope to the treatment of ischemic stroke.

作者信息

Cao Xiang, Li Feifei, Xin Hongliang

机构信息

Department of Pharmacy, Kangda College of Nanjing Medical University, Lianyungang 222000, China; Department of Pharmaceutics, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.

Department of Pharmacy, Kangda College of Nanjing Medical University, Lianyungang 222000, China.

出版信息

Mol Ther. 2024 May 1;32(5):1192-1194. doi: 10.1016/j.ymthe.2024.04.011. Epub 2024 Apr 16.

Abstract
摘要

相似文献

1
VCAM-targeting lipid platform brings new hope to the treatment of ischemic stroke.
Mol Ther. 2024 May 1;32(5):1192-1194. doi: 10.1016/j.ymthe.2024.04.011. Epub 2024 Apr 16.
2
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke.
Mol Ther. 2024 May 1;32(5):1344-1358. doi: 10.1016/j.ymthe.2024.03.004. Epub 2024 Mar 7.
3
A novel specific aptamer targets cerebrovascular endothelial cells after ischemic stroke.
Sci Rep. 2023 Jun 20;13(1):9990. doi: 10.1038/s41598-023-36993-6.
5
Development of endothelial-targeted CD39 as a therapy for ischemic stroke.
J Thromb Haemost. 2024 Aug;22(8):2331-2344. doi: 10.1016/j.jtha.2024.04.023. Epub 2024 May 14.
6
Dexmedetomidine compared to low-dose ketamine better protected not only the brain but also the lungs in acute ischemic stroke.
Int Immunopharmacol. 2023 Nov;124(Pt B):111004. doi: 10.1016/j.intimp.2023.111004. Epub 2023 Sep 29.
7
Intracranial VCAM1 at time of mechanical thrombectomy predicts ischemic stroke severity.
J Neuroinflammation. 2021 May 11;18(1):109. doi: 10.1186/s12974-021-02157-4.
9
MAPK: A Key Player in the Development and Progression of Stroke.
CNS Neurol Disord Drug Targets. 2020;19(4):248-256. doi: 10.2174/1871527319666200613223018.
10
Neural Stem Cells for Early Ischemic Stroke.
Int J Mol Sci. 2021 Jul 19;22(14):7703. doi: 10.3390/ijms22147703.

引用本文的文献

本文引用的文献

1
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke.
Mol Ther. 2024 May 1;32(5):1344-1358. doi: 10.1016/j.ymthe.2024.03.004. Epub 2024 Mar 7.
2
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
3
Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?
Front Immunol. 2021 Jun 23;12:678744. doi: 10.3389/fimmu.2021.678744. eCollection 2021.
4
A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity.
Fluids Barriers CNS. 2020 Nov 18;17(1):69. doi: 10.1186/s12987-020-00230-3.
5
Natural medicine in neuroprotection for ischemic stroke: Challenges and prospective.
Pharmacol Ther. 2020 Dec;216:107695. doi: 10.1016/j.pharmthera.2020.107695. Epub 2020 Sep 28.
6
Update of the organoprotective properties of xenon and argon: from bench to beside.
Intensive Care Med Exp. 2020 Feb 24;8(1):11. doi: 10.1186/s40635-020-0294-6.
7
Current advances in ischemic stroke research and therapies.
Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165260. doi: 10.1016/j.bbadis.2018.09.012. Epub 2018 Sep 15.
8
Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusion‑induced neuroinflammation via activation of AMPK.
Mol Med Rep. 2018 Oct;18(4):3957-3964. doi: 10.3892/mmr.2018.9349. Epub 2018 Aug 3.
10
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验